These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


716 related items for PubMed ID: 18269340

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prebiotics, synbiotics and inflammatory bowel disease.
    Steed H, Macfarlane GT, Macfarlane S.
    Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
    [Abstract] [Full Text] [Related]

  • 3. Clinical usefulness of probiotics in inflammatory bowel diseases.
    Mach T.
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
    [Abstract] [Full Text] [Related]

  • 4. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C, Whelan K, Lindsay JO.
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [Abstract] [Full Text] [Related]

  • 5. Microecology as a target for therapeutic intervention in inflammatory bowel disease.
    Guarner F.
    IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gut microbiota and inflammatory bowel disease.
    Hammer HF.
    Dig Dis; 2011 Sep; 29(6):550-3. PubMed ID: 22179210
    [Abstract] [Full Text] [Related]

  • 10. Clinical utility of probiotics in inflammatory bowel disease.
    Cain AM, Karpa KD.
    Altern Ther Health Med; 2011 Sep; 17(1):72-9. PubMed ID: 21614946
    [Abstract] [Full Text] [Related]

  • 11. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
    Geier MS, Butler RN, Howarth GS.
    Int J Food Microbiol; 2007 Apr 01; 115(1):1-11. PubMed ID: 17137666
    [Abstract] [Full Text] [Related]

  • 12. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
    Prantera C, Scribano ML.
    Curr Opin Gastroenterol; 2009 Jul 01; 25(4):329-33. PubMed ID: 19444096
    [Abstract] [Full Text] [Related]

  • 13. Evolving knowledge and therapy of inflammatory bowel disease.
    Korzenik JR, Podolsky DK.
    Nat Rev Drug Discov; 2006 Mar 01; 5(3):197-209. PubMed ID: 16518373
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P, Dray X, Sokol H, Marteau P.
    Mol Nutr Food Res; 2008 Aug 01; 52(8):906-12. PubMed ID: 18384087
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Probiotics for inflammatory bowel disease: a critical appraisal.
    Sans M.
    Dig Dis; 2009 Aug 01; 27 Suppl 1():111-4. PubMed ID: 20203506
    [Abstract] [Full Text] [Related]

  • 19. Prebiotics in inflammatory bowel diseases.
    Guarner F.
    Br J Nutr; 2007 Oct 01; 98 Suppl 1():S85-9. PubMed ID: 17922967
    [Abstract] [Full Text] [Related]

  • 20. Prebiotics, probiotics and helminths: the 'natural' solution?
    Guarner F.
    Dig Dis; 2009 Oct 01; 27(3):412-7. PubMed ID: 19786773
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.